Browse All

Current Filters

CLEAR FILTER x

TITLE

Phase 3 Myasthenia Gravis Inebilizumab Trial (MINT): Efficacy and Safety Results in Patients with Generalized MG

Correlation Between MG Symptoms PRO and Existing MG-Specific Outcome Scores in the Phase 3 MycarinG Study: Post Hoc Analysis

Author:Pascuzzi, Robert M.   Antozzi, Carlo   Habib, Ali A.   Kaminski, Henry J.   Sacconi, Sabrina   Utsugisawa, Kimiaki   Vissing, John   Regnault, Antoine   Bloemers, Jos   Grimson, Fiona   Tarancón, Thaïs   Bril, Vera   

Session Name:P1: Neuromuscular and Clinical Neurophysiology (EMG): Myasthenia Gravis 1  

Topic:Neuromuscular and Clinical Neurophysiology (EMG)  

Program Number:P1.026  

Author Institution:Neurology Department, Indiana University School of Medicine, Indiana University Health, Indianapolis, IN, USA, Indianapolis, IN  Neuroimmunology and Muscle Pathology Unit, Multiple Sclerosis Center, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico, Istituto Nazionale Neurologico Carlo Besta, Milan, Italy, Milan, Italy  MDA ALS & Neuromuscular Center, Department of Neurology, University of California, Irvine, Orange, CA, USA, Orange, CA  Department of Neurology & Rehabilitation Medicine, George Washington University, Washington, DC, USA, Washington, DC  Université Côte d'Azur, Peripheral Nervous System & Muscle Department, Pasteur 2 Hospital, Centre Hospitalier Universitaire de Nice, Nice, France, Nice, France  Department of Neurology, Hanamaki General Hospital, Hanamaki, Japan, Hanamaki, Japan  Department of Neurology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark, Copenhagen, Denmark  Modus Outcomes, A Division of THREAD, Lyon, France, Lyon , France  UCB, Brussels, Belgium, Brussels, Belgium  UCB, Slough, UK, Slough, United Kingdom  UCB, Madrid, Spain, Madrid, Spain  University Health Network, Toronto, ON, Canada, Toronto, ON, Canada